Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) Estimate
Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) Estimate
Acumen Pharmaceuticals第四季度每股收益美元(0.29美元)未达到预期(0.26美元)
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.
Acumen Pharmicals(纳斯达克股票代码:ABOS)公布的季度亏损为每股0.29美元,比分析师普遍预期的0.26美元(0.26美元)低11.54%。这比去年同期每股亏损0.32美元(0.32美元)增长了9.38%。